About Aziyo Biologics
Aziyo Biologics is a company based in Silver Spring (United States) founded in 2015.. Aziyo Biologics has raised $49.59 million across 6 funding rounds from investors including HighCape Capital, Deerfield and Birchview Capital. The company has 162 employees as of December 31, 2022. Aziyo Biologics offers products and services including CanGaroo, SimpliDerm, and EluPro. Aziyo Biologics operates in a competitive market with competitors including TISSIUM, Theradaptive, MiMedx Group, Ossio and Cardival Medical, among others.
- Headquarter Silver Spring, United States
- Employees 162 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aziyo Biologics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$49.59 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
HighCape Capital
& 2 more
-
Employee Count
162
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aziyo Biologics
Aziyo Biologics offers a comprehensive portfolio of products and services, including CanGaroo, SimpliDerm, and EluPro. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Secures implants like pacemakers to prevent migration and aid healing.
Used for soft tissue repair in reconstruction procedures.
Optimizes stability for cardiac implantable electronic devices.
Unlock access to complete
Unlock access to complete
Funding Insights of Aziyo Biologics
Aziyo Biologics has successfully raised a total of $49.59M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(01 Jun 2015)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Post-IPO - Aziyo Biologics | Valuation |
investors |
|
| Sep, 2020 | Amount | Series C - Aziyo Biologics | Valuation |
investors |
|
| Dec, 2019 | Amount | Series B - Aziyo Biologics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aziyo Biologics
Aziyo Biologics has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include HighCape Capital, Deerfield and Birchview Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science companies are targeted for private equity investments.
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Business growth and value creation are facilitated by Birchview Capital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aziyo Biologics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aziyo Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aziyo Biologics Comparisons
Competitors of Aziyo Biologics
Aziyo Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Theradaptive, MiMedx Group, Ossio and Cardival Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| domain | founded_year | HQ Location |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| domain | founded_year | HQ Location |
A device for vascular access management is developed.
|
|
| domain | founded_year | HQ Location |
AV fistula maturation and patency are supported by VasQ device.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aziyo Biologics
Frequently Asked Questions about Aziyo Biologics
When was Aziyo Biologics founded?
Aziyo Biologics was founded in 2015.
Where is Aziyo Biologics located?
Aziyo Biologics is headquartered in Silver Spring, United States. It is registered at Silver Spring, Maryland, United States.
Who is the current CEO of Aziyo Biologics?
Ron Lloyd is the current CEO of Aziyo Biologics.
Is Aziyo Biologics a funded company?
Aziyo Biologics is a funded company, having raised a total of $49.59M across 6 funding rounds to date. The company's 1st funding round was a Series B of $3.05M, raised on Jun 01, 2015.
How many employees does Aziyo Biologics have?
As of Dec 31, 2022, the latest employee count at Aziyo Biologics is 162.
What does Aziyo Biologics do?
Founded in 2015 and based in Silver Spring, United States, regenerative medicine products are developed by Aziyo Biologics for use in orthopedic, cardiovascular, and other medical specialties. Natural healing mechanisms are leveraged in these products to support clinical applications across multiple sectors. Operations focus on innovation within the biotechnology field, with an emphasis on therapeutic solutions for diverse medical needs.
Who are the top competitors of Aziyo Biologics?
Aziyo Biologics's top competitors include TISSIUM, EpiBone and Theradaptive.
What products or services does Aziyo Biologics offer?
Aziyo Biologics offers CanGaroo, SimpliDerm, and EluPro.
Who are Aziyo Biologics's investors?
Aziyo Biologics has 3 investors. Key investors include HighCape Capital, Deerfield, and Birchview Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.